쎌바이오텍
049960KOSDAQ· 의료용 물질 및 의약품 제조업15,500원+100 (+0.65%)전일 종가 2026-09-18
52주 위치
11,35018,50058%신고가 대비 -16.22%
- 시가총액
- 1,457억
- PER
- 6.32
- PBR
- 1.07
- EPS(TTM)
- 2,454원
- BPS
- 14,547원
- 배당수익률
- 3.87%
- 자사주비율
- 27.19%
- 결산월
- 12월
알림 만들기관심종목·메모·논지·저널은 로그인하면 사용 가능
| 항목 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE | 9.73% | 7.71% | 5.73% | 12.82% | 7.92% |
| ROA | 9.20% | 7.24% | 5.40% | 12.20% | 7.59% |
| 영업이익률 | 15.48% | 11.98% | 4.08% | 13.62% | 14.90% |
| 순이익률 | 22.15% | 16.39% | 11.72% | 30.31% | 19.06% |
| 매출총이익률 | 76.13% | 75.11% | 72.46% | 72.25% | 72.70% |
| 부채비율 | 5.80% | 7.17% | 5.14% | 5.02% | 3.75% |
| 유동비율 | 1171.01% | 1023.90% | 1699.32% | 1657.05% | 2133.73% |
| 매출 성장률(YoY) | — | 7.79% | 6.46% | -7.20% | 6.44% |
| 영업이익 성장률(YoY) | — | -16.61% | -63.72% | 209.56% | 16.45% |
| 순이익 성장률(YoY) | — | -20.25% | -23.87% | 139.97% | -33.06% |
| FCF | 140억 | 104억 | 62.64억 | 181억 | 80.04억 |
| FCF 마진 | 29.96% | 20.67% | 11.65% | 36.34% | 15.07% |
| CAPEX/매출 | 1.81% | 4.69% | 2.88% | 2.26% | 5.84% |
| 항목 | 2021 3Q | 2021 4Q | 2022 1Q | 2022 2Q | 2022 3Q | 2022 4Q | 2023 1Q | 2023 2Q | 2023 3Q | 2023 4Q | 2024 1Q | 2024 2Q | 2024 3Q | 2024 4Q | 2025 1Q | 2025 2Q | 2025 3Q | 2025 4Q | 2026 1Q | 2026 2Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 3.73% | 2.75% | 2.93% | 3.02% | 5.16% | -3.20% | 2.71% | -2.11% | 2.71% | 2.46% | 2.97% | 3.64% | 0.86% | 5.81% | 1.76% | 0.18% | 2.82% | 3.43% | 4.18% | 2.77% |
| ROA | 3.48% | 2.60% | 2.68% | 2.85% | 4.80% | -3.00% | 2.51% | -1.98% | 2.51% | 2.32% | 2.76% | 3.42% | 0.81% | 5.53% | 1.63% | 0.17% | 2.68% | 3.29% | 3.88% | 2.63% |
| 영업이익률 | 23.49% | 18.93% | 16.55% | 4.25% | 16.56% | 10.68% | 8.06% | -24.41% | 13.27% | 16.06% | 8.22% | 19.98% | 17.17% | 9.27% | 12.13% | 10.76% | 14.43% | 20.88% | 21.83% | 10.37% |
| 순이익률 | 30.50% | 24.34% | 24.87% | 25.99% | 44.54% | -24.86% | 22.24% | -17.85% | 21.68% | 18.24% | 25.01% | 32.15% | 7.97% | 56.43% | 18.43% | 1.79% | 22.46% | 30.02% | 36.66% | 22.80% |
| 매출총이익률 | 74.14% | 77.79% | 75.31% | 77.04% | 73.40% | 74.78% | 73.54% | 73.11% | 73.68% | 69.86% | 71.66% | 73.23% | 71.32% | 72.78% | 71.10% | 74.68% | 71.86% | 73.22% | 73.06% | 73.17% |
| 부채비율 | 6.90% | 5.80% | 9.00% | 6.02% | 7.89% | 7.17% | 7.27% | 7.18% | 7.37% | 5.14% | 7.96% | 5.79% | 5.11% | 5.02% | 7.53% | 4.91% | 5.87% | 3.75% | 7.71% | 5.98% |
| 유동비율 | 1073.77% | 1171.01% | 799.11% | 1009.53% | 909.80% | 1023.90% | 998.04% | 983.24% | 1158.20% | 1699.32% | 1059.94% | 1455.27% | 1633.08% | 1657.05% | 1107.89% | 1636.68% | 1372.38% | 2133.73% | 1050.40% | 1353.44% |
| 매출 성장률(YoY) | — | — | — | — | -2.57% | 14.73% | 6.16% | 1.94% | 10.00% | 7.51% | 1.50% | 0.94% | -10.96% | -18.10% | -13.87% | -5.16% | 26.25% | 20.38% | 30.00% | 32.78% |
| 영업이익 성장률(YoY) | — | — | — | — | -31.32% | -35.28% | -48.27% | -685.95% | -11.85% | 61.67% | 3.41% | — | 15.25% | -52.72% | 27.14% | -48.93% | 6.09% | 170.99% | 134.00% | 27.97% |
| 순이익 성장률(YoY) | — | — | — | — | 42.31% | -217.13% | -5.07% | -170.02% | -46.46% | — | 14.17% | — | -67.28% | 153.44% | -36.53% | -94.71% | 255.88% | -35.96% | 158.57% | 1589.38% |
| FCF | 60.81억 | 25.46억 | 65.42억 | -34.05억 | 59.3억 | 13.78억 | 1.31억 | -8.23억 | 26.02억 | 43.55억 | 31.13억 | 75.05억 | 32.28억 | 42.92억 | 14.98억 | 7.19억 | 18.78억 | 39.1억 | -5.31억 | 55.72억 |
| FCF 마진 | 47.71% | 21.16% | 54.07% | -27.90% | 47.76% | 9.98% | 1.02% | -6.62% | 19.05% | 29.34% | 23.88% | 59.77% | 26.54% | 35.31% | 13.34% | 6.04% | 12.23% | 26.72% | -3.64% | 35.23% |
| CAPEX/매출 | 2.25% | 1.34% | 4.25% | 3.37% | 7.74% | 3.50% | 7.22% | 2.78% | 0.62% | 1.30% | 1.34% | 2.24% | 2.12% | 3.42% | 0.86% | 3.81% | 14.78% | 1.94% | 29.05% | 2.91% |
출처 DART 재무제표 원값으로 자체 계산· 갱신 2026-09-21 04:49· 연결 · 산식은 항목 툴팁